Skip to content

Deals
Sectors
- Aerospace
- AI
- Blockchain
- Climate
- Consumer
- Education
- Entertainment
- Fintech
- Healthcare
- Internet
- Mobility
- Smart Hardware
- VR/AR
Insights
中文版

Menu

Deals
Sectors
- Aerospace
- AI
- Blockchain
- Climate
- Consumer
- Education
- Entertainment
- Fintech
- Healthcare
- Internet
- Mobility
- Smart Hardware
- VR/AR
Insights
中文版

Search

Search

Close this search box.

biopharma industry

Healthcare

China Biologic Receives Higher Counter Bid From Investor Group Led By Ex-CEO

August 21, 2018 — 14:26

Home
About Us
Contact Us
Privacy
Terms & Conditions

Menu

Home
About Us
Contact Us
Privacy
Terms & Conditions

© 2024 China Money Network. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.